Table 1 Description of study population
Prevalence, n: 1.450* | ||
|---|---|---|
Variables | Test pos.; % (n) | Test neg.; % (n) |
n | 138 | 1312 |
Age; ma | 43 | 40 |
Contact to a person with COVID-19, N = 107 | 34.1 (47) | 5.1 (60) |
Gender | ||
Female | 45.7 (59) | 46.3 (578) |
Male | 54.3 (70) | 53.7 (671) |
Days since symptom onset | ||
Day 1–3 | 66.7 (84) | 73.4 (886) |
Day 3–7 | 27 (34) | 20.6 (249) |
Day > 7 | 6.3 (8) | 6 (72) |